[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PA8606601A1 - Sistemas emulsionantes que contienen derivados de azetidina - Google Patents

Sistemas emulsionantes que contienen derivados de azetidina

Info

Publication number
PA8606601A1
PA8606601A1 PA20048606601A PA8606601A PA8606601A1 PA 8606601 A1 PA8606601 A1 PA 8606601A1 PA 20048606601 A PA20048606601 A PA 20048606601A PA 8606601 A PA8606601 A PA 8606601A PA 8606601 A1 PA8606601 A1 PA 8606601A1
Authority
PA
Panama
Prior art keywords
azetidine
emulsioning
systems containing
containing derivatives
derivatives
Prior art date
Application number
PA20048606601A
Other languages
English (en)
Inventor
Cote Sophie
Maria-Teresa Peracchia
Valerie Bobineau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of PA8606601A1 publication Critical patent/PA8606601A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SISTEMAS EMULSIONANTES QUE CONTIENEN DERIVADOS DE AZETIDINA. SISTEMAS EMULSIONANTES QUE CONTIENEN DERIVADOS DE AZETIDINA. LA PRESENTE INVENCION SE REFIERE A NUEVAS FORMULACIONES DE DERIVADOS DE AZETIDINA PARA ADMINISTRACION ORAL.
PA20048606601A 2003-07-18 2004-07-14 Sistemas emulsionantes que contienen derivados de azetidina PA8606601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291797A EP1498123A1 (en) 2003-07-18 2003-07-18 Emulsifying systems containing azetidine derivatives

Publications (1)

Publication Number Publication Date
PA8606601A1 true PA8606601A1 (es) 2005-03-03

Family

ID=33462260

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20048606601A PA8606601A1 (es) 2003-07-18 2004-07-14 Sistemas emulsionantes que contienen derivados de azetidina

Country Status (31)

Country Link
US (1) US20050037062A1 (es)
EP (2) EP1498123A1 (es)
JP (1) JP2009513559A (es)
KR (1) KR20060040690A (es)
CN (1) CN1822830A (es)
AR (1) AR045912A1 (es)
AU (1) AU2004262497A1 (es)
BR (1) BRPI0412239A (es)
CA (1) CA2532668A1 (es)
CR (1) CR8178A (es)
EC (1) ECSP066291A (es)
GT (1) GT200400134A (es)
HR (1) HRP20060021A2 (es)
IL (1) IL173113A0 (es)
MA (1) MA27921A1 (es)
MX (1) MXPA06000478A (es)
MY (1) MY142076A (es)
NO (1) NO20060510L (es)
NZ (1) NZ544707A (es)
OA (1) OA13190A (es)
PA (1) PA8606601A1 (es)
PE (1) PE20050699A1 (es)
RS (1) RS20050971A (es)
RU (1) RU2348615C2 (es)
SG (1) SG144140A1 (es)
TN (1) TNSN06012A1 (es)
TW (1) TW200522946A (es)
UA (1) UA82539C2 (es)
UY (1) UY28422A1 (es)
WO (1) WO2005013972A1 (es)
ZA (1) ZA200600489B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1498122A1 (en) * 2003-07-18 2005-01-19 Aventis Pharma S.A. Semi-solid systems containing azetidine derivatives
JP2009513642A (ja) * 2005-10-25 2009-04-02 アボット・ラボラトリーズ 低水溶解度の薬剤を含む製剤およびそれの使用方法
CN102159143A (zh) * 2006-09-29 2011-08-17 普拉罗美德公司 碎石术期间预防结石和结石碎片后退的方法
MX2010001730A (es) * 2007-08-21 2010-03-10 Basilea Pharmaceutica Ag Composicion antimicotica.
FR2923719B1 (fr) * 2007-11-15 2009-11-20 Sanofi Aventis Compositions pharmaceutiques a base de derives d'azetidine
IT1394400B1 (it) * 2009-02-25 2012-06-15 Neuroscienze Pharmaness S C Ar L Composizioni farmaceutiche
US9918965B2 (en) 2015-04-10 2018-03-20 Bioresponse, L.L.C. Self-emulsifying formulations of DIM-related indoles
CN111759823B (zh) * 2015-09-17 2022-12-30 阿赖耶识（上海）生物技术有限公司 一种高稳定的非囊泡型纳米颗粒及其在治疗微生物感染中的应用
CA3060581A1 (en) 2017-05-02 2018-11-08 Merck Sharp & Dohme Corp. Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
JOP20190260A1 (ar) 2017-05-02 2019-10-31 Merck Sharp & Dohme صيغ ثابتة لأجسام مضادة لمستقبل الموت المبرمج 1 (pd-1) وطرق استخدامها
EP4351515A1 (en) * 2021-06-11 2024-04-17 Universidade Da Beira Interior Self-emulsifying composition, production methods and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
JP2740153B2 (ja) * 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2814678B1 (fr) * 2000-10-04 2002-12-20 Aventis Pharma Sa Association d'un antagoniste du recepteur cb1 et de sibutramine, les compositions pharmaceutiques les contenant et leur utilisation pour la traitement de l'obesite
FR2829027A1 (fr) * 2001-08-29 2003-03-07 Aventis Pharma Sa Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson
FR2833842B1 (fr) * 2001-12-21 2004-02-13 Aventis Pharma Sa Compositions pharmaceutiques a base de derives d'azetidine

Also Published As

Publication number Publication date
EP1648441A1 (en) 2006-04-26
MXPA06000478A (es) 2006-04-05
MA27921A1 (fr) 2006-06-01
RU2006105000A (ru) 2006-07-10
AR045912A1 (es) 2005-11-16
CN1822830A (zh) 2006-08-23
NO20060510L (no) 2006-01-31
AU2004262497A2 (en) 2005-02-17
PE20050699A1 (es) 2005-09-15
UY28422A1 (es) 2005-02-28
IL173113A0 (en) 2006-06-11
TNSN06012A1 (en) 2007-10-03
US20050037062A1 (en) 2005-02-17
NZ544707A (en) 2009-01-31
BRPI0412239A (pt) 2006-09-12
MY142076A (en) 2010-08-30
RS20050971A (en) 2008-06-05
AU2004262497A1 (en) 2005-02-17
ZA200600489B (en) 2007-04-25
UA82539C2 (en) 2008-04-25
WO2005013972A1 (en) 2005-02-17
EP1498123A1 (en) 2005-01-19
ECSP066291A (es) 2006-07-28
SG144140A1 (en) 2008-07-29
JP2009513559A (ja) 2009-04-02
OA13190A (en) 2006-12-13
CA2532668A1 (en) 2005-02-17
TW200522946A (en) 2005-07-16
HRP20060021A2 (en) 2006-02-28
KR20060040690A (ko) 2006-05-10
RU2348615C2 (ru) 2009-03-10
GT200400134A (es) 2005-02-22
CR8178A (es) 2007-12-04

Similar Documents

Publication Publication Date Title
ECSP066291A (es) Sistemas emulsionantes que contienen derivados de azetidina
HN2003000408A (es) Nuevos derivados de fluoroglicosidos heterociclicos, medicamentos que contienen estos compuestos, y el uso de los mismos.
BR0316027A (pt) Formulações de toxina botulina para administração oral
CR8051A (es) Compuestos farmaceuticos novedosos
HN2003000407A (es) Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos.
UY28215A1 (es) Quinazolinas utiles como moduladores de canales iónicos
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
HK1076605A1 (en) Formulations
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
HN2002000300A (es) Nuevos derivados de piperazina
AR062211A1 (es) Derivados de 6-carboxi-normorfinano. composiciones farmaceuticas
BRPI0408895A (pt) formulações de cladribina para administração oral e transmucosal aperfeiçoada
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
ECSP066292A (es) Sistemas semi-sólidos que contienen derivados de azetidina
BRPI0408848A (pt) formulações orais de cladribine
MXPA06000636A (es) Formulaciones semi-solidas para la administracion oral de taxoides.
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
HN2002000082A (es) Composiciones que contienen imidazotriazinona para administracion nasal
HN2002000331A (es) Composiciones farmaceuticas de 5,7,14-triazatetra-ciclo (10.3.1.02,11.04,9)-hexadeca-2(11) 3,5,7,9-pentaeno
HN2002000084A (es) Fenil - heterociclil - eteres
HN2002000049A (es) Nuevos compuestos antiinflamatorios de triazolopiridinas
HN2000000083A (es) Complejo farmaceutico
HN2000000279A (es) Composiciones farmaceuticas que proporcionan concentraciones potenciales de farmaco.
DOP2004000892A (es) Compuestos farmaceuticos novedosos